Skip to main content
Premium Trial:

Request an Annual Quote

IDBS Providing Data Management Tool to Genomic Health

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IDBS today said it will provide tools to Genomic Health for its new clinical research data management and decision-capture platform.

Financial terms of the agreement were not disclosed.

Genomic Health develops oncology molecular diagnostics using gene expression technologies, and has two clinically validated assays for breast cancer and colon cancer. As the company generates increasing amounts of data, IDBS' tools will help Genomic Health capture genomic data from the platforms and enable scientists to query the data across multiple experiments, Guildford, UK-based IDBS said in a statement.

The tools will also provide Genomic Health researchers easy access to necessary data to run experiments and ensure that all intellectual property is "effectively captured at the point of invention."

"As we have expanded and refined our assays, the amount and heterogeneity of data generated has increased significantly, and the IDBS platform will help us manage the data today and as our organization continues to grow in the future," said Joel Robertson, senior manager of LIMS software for Genomic Health.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.